-
3
-
-
84907079081
-
-
[last cited on 2004 Mar 11] [last accessed on 2008 Jan 13]
-
Economist T. Fixing the drugs pipeline. Available from: http://www.economist.com/printedition/displayStory.cfm?Story_ID=2477075 [last cited on 2004 Mar 11] [last accessed on 2008 Jan 13].
-
Fixing the drugs pipeline
-
-
Economist, T.1
-
4
-
-
70749155380
-
Oral drug delivery: Prospects and challenges
-
7
-
Rocca JG, Park K. Oral drug delivery: Prospects and challenges. Drug Deliv Technol 2004;4:52-4, 7.
-
(2004)
Drug Deliv Technol
, vol.4
, pp. 52-54
-
-
Rocca, JG1
Park, K.2
-
5
-
-
85089917724
-
-
Database SS. [last accessed on 2010 Mar 8]
-
Database SS. Available from: http://www.cas.org/support/scifi/index. html [last accessed on 2010 Mar 8].
-
-
-
-
7
-
-
85089907872
-
-
Pfizer. Timeline 1951-1999 [last accessed on 2010 Mar 8]
-
Pfizer. Available from: http://www.pfizer.com/about/history/1951_1999. jsp. Timeline 1951-1999 [last accessed on 2010 Mar 8].
-
-
-
-
8
-
-
67649156827
-
-
Penwest. [last accessed on 2010 Mar 8]
-
Penwest. Drug delivery technologies. Available from: http://www.penwest.com/drug_del_tech.html [last accessed on 2010 Mar 8].
-
Drug delivery technologies
-
-
-
11
-
-
84892537488
-
Controlled-release multiple-units and single-unit doses: A literature review
-
Bechgaard H, Nielsen GH. Controlled-release multiple-units and single-unit doses: A literature review. Drug Dev Ind Pharm 1978;4:53-67.
-
(1978)
Drug Dev Ind Pharm
, vol.4
, pp. 53-67
-
-
Bechgaard, H1
Nielsen, GH.2
-
12
-
-
85089911335
-
-
Elan. [last accessed on 2010 Mar 8]
-
Elan. Oral Controlled release technologies. Available from: http:// wwwelancom/EDT/oral_controlled_release_technology/ [last accessed on 2010 Mar 8].
-
Oral Controlled release technologies
-
-
-
13
-
-
85089896810
-
-
Naprelan. [last accessed on 2010 Mar 8]
-
Naprelan. Available from: http://www.naprelan375.com/home.html [last accessed on 2010 Mar 8].
-
-
-
-
14
-
-
77958110659
-
Chronotherapeutics and Pharmaceutical Care
-
[last accessed on 2008 Feb 11]
-
Mangione RA. Chronotherapeutics and Pharmaceutical Care. US Pharmacist. 22:7. Available from: http://www.uspharmacist.com/oldformat.asp?url=newlook/files/Feat/ACF2F15.cfmand pub_ id=8andarticle_id=48 [last accessed on 2008 Feb 11].
-
US Pharmacist
, vol.22
, pp. 7
-
-
Mangione, RA.1
-
15
-
-
33646639014
-
Formulation design of double-layer in the outer shell of drycoated tablet to modulate lag time and time-controlled dissolution function: Studies on micronized ethylcellulose for dosage form design (VII)
-
Lin SY, Lin KH, Li MJ. Formulation design of double-layer in the outer shell of drycoated tablet to modulate lag time and time-controlled dissolution function: Studies on micronized ethylcellulose for dosage form design (VII). AAPS J 2004;6:e17.
-
(2004)
AAPS J
, vol.6
, pp. e17
-
-
Lin, SY1
Lin, KH2
Li, MJ.3
-
16
-
-
1842865536
-
Melt extrusion: From process to drug delivery technology
-
Breitenbach J. Melt extrusion: From process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107-17.
-
(2002)
Eur J Pharm Biopharm
, vol.54
, pp. 107-117
-
-
Breitenbach, J.1
-
18
-
-
0035451275
-
Ion-exchange resins: Carrying drug delivery forward
-
Anand V, Kandarapu R, Garg S. Ion-exchange resins: Carrying drug delivery forward. Drug Discov Today 2001;6:905-14.
-
(2001)
Drug Discov Today
, vol.6
, pp. 905-914
-
-
Anand, V1
Kandarapu, R2
Garg, S.3
-
21
-
-
33947176102
-
PTI-821: Sustained-release oxycodone using gel-cap technology
-
Webster LR. PTI-821: Sustained-release oxycodone using gel-cap technology. Expert Opin Investig Drugs 2007;16:359-66.
-
(2007)
Expert Opin Investig Drugs
, vol.16
, pp. 359-366
-
-
Webster, LR.1
-
23
-
-
0037299865
-
Eligard: Leuprolide acetate in a novel sustained-release delivery system
-
Sartor O. Eligard: Leuprolide acetate in a novel sustained-release delivery system. Urology 2003;61:25-31.
-
(2003)
Urology
, vol.61
, pp. 25-31
-
-
Sartor, O.1
-
24
-
-
85089897988
-
-
Wikipedia. [last accessed 2008 Mar 31]
-
Wikipedia. Leuprolide acetate. Available from: http://www.enwikipediaorg/wiki/Eligard [last accessed 2008 Mar 31].
-
Leuprolide acetate
-
-
-
25
-
-
0033963035
-
Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide
-
Ravivarapu HB, Moyer KL, Dunn RL. Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int J Pharm 2000;194:181-91.
-
(2000)
Int J Pharm
, vol.194
, pp. 181-191
-
-
Ravivarapu, HB1
Moyer, KL2
Dunn, RL.3
|